The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardioembolic Stroke Closure Devices Market Research Report 2024
Synopsis
Cardioembolic stroke occluder products mainly consist of PFO occluder and LAA occluder.
Global Cardioembolic Stroke Closure Devices market is projected to reach US$ 2822.1 million in 2029, increasing from US$ 1238 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardioembolic Stroke Closure Devices market research.
The cardioembolic stroke occluder market is driven by the increasing incidence of ischemic strokes caused by cardioembolism and the growing demand for minimally invasive treatment options. Cardioembolic stroke occluders are medical devices used to prevent recurrent strokes by closing off the source of the emboli in the heart. The rise in cardiovascular diseases and atrial fibrillation contribute to market growth as these conditions increase the risk of cardioembolic strokes. Moreover, advancements in medical technology and the development of innovative occluder designs have improved the safety and efficacy of the procedure. However, the market also faces challenges, including the complexity of treating cardioembolic strokes and the need for specialized training for healthcare professionals. Additionally, addressing the cost of occluder devices and ensuring appropriate patient selection can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer advanced and reliable cardioembolic stroke occluders, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and minimally invasive treatment options for cardioembolic strokes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardioembolic Stroke Closure Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Segment by Type
PFO Closure Devices
LAA Closure Devices
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cardioembolic Stroke Closure Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Cardioembolic stroke occluder products mainly consist of PFO occluder and LAA occluder.
Global Cardioembolic Stroke Closure Devices market is projected to reach US$ 2822.1 million in 2029, increasing from US$ 1238 million in 2022, with the CAGR of 12.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardioembolic Stroke Closure Devices market research.
The cardioembolic stroke occluder market is driven by the increasing incidence of ischemic strokes caused by cardioembolism and the growing demand for minimally invasive treatment options. Cardioembolic stroke occluders are medical devices used to prevent recurrent strokes by closing off the source of the emboli in the heart. The rise in cardiovascular diseases and atrial fibrillation contribute to market growth as these conditions increase the risk of cardioembolic strokes. Moreover, advancements in medical technology and the development of innovative occluder designs have improved the safety and efficacy of the procedure. However, the market also faces challenges, including the complexity of treating cardioembolic strokes and the need for specialized training for healthcare professionals. Additionally, addressing the cost of occluder devices and ensuring appropriate patient selection can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer advanced and reliable cardioembolic stroke occluders, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and minimally invasive treatment options for cardioembolic strokes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardioembolic Stroke Closure Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Segment by Type
PFO Closure Devices
LAA Closure Devices
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cardioembolic Stroke Closure Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Cardioembolic Stroke Closure Devices Market Overview
1.1 Product Overview and Scope of Cardioembolic Stroke Closure Devices
1.2 Cardioembolic Stroke Closure Devices Segment by Type
1.2.1 Global Cardioembolic Stroke Closure Devices Market Value Comparison by Type (2023-2029)
1.2.2 PFO Closure Devices
1.2.3 LAA Closure Devices
1.3 Cardioembolic Stroke Closure Devices Segment by Application
1.3.1 Global Cardioembolic Stroke Closure Devices Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Cardioembolic Stroke Closure Devices Market Size Estimates and Forecasts
1.4.1 Global Cardioembolic Stroke Closure Devices Revenue 2018-2029
1.4.2 Global Cardioembolic Stroke Closure Devices Sales 2018-2029
1.4.3 Global Cardioembolic Stroke Closure Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cardioembolic Stroke Closure Devices Market Competition by Manufacturers
2.1 Global Cardioembolic Stroke Closure Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cardioembolic Stroke Closure Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cardioembolic Stroke Closure Devices Average Price by Manufacturers (2018-2023)
2.4 Global Cardioembolic Stroke Closure Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cardioembolic Stroke Closure Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardioembolic Stroke Closure Devices, Product Type & Application
2.7 Cardioembolic Stroke Closure Devices Market Competitive Situation and Trends
2.7.1 Cardioembolic Stroke Closure Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardioembolic Stroke Closure Devices Players Market Share by Revenue
2.7.3 Global Cardioembolic Stroke Closure Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardioembolic Stroke Closure Devices Retrospective Market Scenario by Region
3.1 Global Cardioembolic Stroke Closure Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cardioembolic Stroke Closure Devices Global Cardioembolic Stroke Closure Devices Sales by Region: 2018-2029
3.2.1 Global Cardioembolic Stroke Closure Devices Sales by Region: 2018-2023
3.2.2 Global Cardioembolic Stroke Closure Devices Sales by Region: 2024-2029
3.3 Global Cardioembolic Stroke Closure Devices Global Cardioembolic Stroke Closure Devices Revenue by Region: 2018-2029
3.3.1 Global Cardioembolic Stroke Closure Devices Revenue by Region: 2018-2023
3.3.2 Global Cardioembolic Stroke Closure Devices Revenue by Region: 2024-2029
3.4 North America Cardioembolic Stroke Closure Devices Market Facts & Figures by Country
3.4.1 North America Cardioembolic Stroke Closure Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cardioembolic Stroke Closure Devices Sales by Country (2018-2029)
3.4.3 North America Cardioembolic Stroke Closure Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardioembolic Stroke Closure Devices Market Facts & Figures by Country
3.5.1 Europe Cardioembolic Stroke Closure Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cardioembolic Stroke Closure Devices Sales by Country (2018-2029)
3.5.3 Europe Cardioembolic Stroke Closure Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardioembolic Stroke Closure Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Cardioembolic Stroke Closure Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cardioembolic Stroke Closure Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Cardioembolic Stroke Closure Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardioembolic Stroke Closure Devices Market Facts & Figures by Country
3.7.1 Latin America Cardioembolic Stroke Closure Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cardioembolic Stroke Closure Devices Sales by Country (2018-2029)
3.7.3 Latin America Cardioembolic Stroke Closure Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardioembolic Stroke Closure Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardioembolic Stroke Closure Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cardioembolic Stroke Closure Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cardioembolic Stroke Closure Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardioembolic Stroke Closure Devices Sales by Type (2018-2029)
4.1.1 Global Cardioembolic Stroke Closure Devices Sales by Type (2018-2023)
4.1.2 Global Cardioembolic Stroke Closure Devices Sales by Type (2024-2029)
4.1.3 Global Cardioembolic Stroke Closure Devices Sales Market Share by Type (2018-2029)
4.2 Global Cardioembolic Stroke Closure Devices Revenue by Type (2018-2029)
4.2.1 Global Cardioembolic Stroke Closure Devices Revenue by Type (2018-2023)
4.2.2 Global Cardioembolic Stroke Closure Devices Revenue by Type (2024-2029)
4.2.3 Global Cardioembolic Stroke Closure Devices Revenue Market Share by Type (2018-2029)
4.3 Global Cardioembolic Stroke Closure Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cardioembolic Stroke Closure Devices Sales by Application (2018-2029)
5.1.1 Global Cardioembolic Stroke Closure Devices Sales by Application (2018-2023)
5.1.2 Global Cardioembolic Stroke Closure Devices Sales by Application (2024-2029)
5.1.3 Global Cardioembolic Stroke Closure Devices Sales Market Share by Application (2018-2029)
5.2 Global Cardioembolic Stroke Closure Devices Revenue by Application (2018-2029)
5.2.1 Global Cardioembolic Stroke Closure Devices Revenue by Application (2018-2023)
5.2.2 Global Cardioembolic Stroke Closure Devices Revenue by Application (2024-2029)
5.2.3 Global Cardioembolic Stroke Closure Devices Revenue Market Share by Application (2018-2029)
5.3 Global Cardioembolic Stroke Closure Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Cardioembolic Stroke Closure Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Cardioembolic Stroke Closure Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 LifeTech
6.3.1 LifeTech Corporation Information
6.3.2 LifeTech Description and Business Overview
6.3.3 LifeTech Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LifeTech Cardioembolic Stroke Closure Devices Product Portfolio
6.3.5 LifeTech Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lepu Medical Cardioembolic Stroke Closure Devices Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Corporation Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Occlutech Cardioembolic Stroke Closure Devices Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 W. L. Gore & Associates
6.6.1 W. L. Gore & Associates Corporation Information
6.6.2 W. L. Gore & Associates Description and Business Overview
6.6.3 W. L. Gore & Associates Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 W. L. Gore & Associates Cardioembolic Stroke Closure Devices Product Portfolio
6.6.5 W. L. Gore & Associates Recent Developments/Updates
6.7 Starway
6.6.1 Starway Corporation Information
6.6.2 Starway Description and Business Overview
6.6.3 Starway Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Starway Cardioembolic Stroke Closure Devices Product Portfolio
6.7.5 Starway Recent Developments/Updates
6.8 Coherex Medical
6.8.1 Coherex Medical Corporation Information
6.8.2 Coherex Medical Description and Business Overview
6.8.3 Coherex Medical Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Coherex Medical Cardioembolic Stroke Closure Devices Product Portfolio
6.8.5 Coherex Medical Recent Developments/Updates
6.9 Cardia
6.9.1 Cardia Corporation Information
6.9.2 Cardia Description and Business Overview
6.9.3 Cardia Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cardia Cardioembolic Stroke Closure Devices Product Portfolio
6.9.5 Cardia Recent Developments/Updates
6.10 MicroPort
6.10.1 MicroPort Corporation Information
6.10.2 MicroPort Description and Business Overview
6.10.3 MicroPort Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 MicroPort Cardioembolic Stroke Closure Devices Product Portfolio
6.10.5 MicroPort Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardioembolic Stroke Closure Devices Industry Chain Analysis
7.2 Cardioembolic Stroke Closure Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardioembolic Stroke Closure Devices Production Mode & Process
7.4 Cardioembolic Stroke Closure Devices Sales and Marketing
7.4.1 Cardioembolic Stroke Closure Devices Sales Channels
7.4.2 Cardioembolic Stroke Closure Devices Distributors
7.5 Cardioembolic Stroke Closure Devices Customers
8 Cardioembolic Stroke Closure Devices Market Dynamics
8.1 Cardioembolic Stroke Closure Devices Industry Trends
8.2 Cardioembolic Stroke Closure Devices Market Drivers
8.3 Cardioembolic Stroke Closure Devices Market Challenges
8.4 Cardioembolic Stroke Closure Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
